4Moving Biotech Targets Synovitis with Intra-Articular GLP-1 Therapy
LILLE & PARIS, France, Aug. 4, 2026 4Moving Biotech (4MB) announced the completion of patient enrollment in the Phase...
Bio-Pharma
Advertisement
Dr. Reddy’s Expands Access to Immunotherapy for Rare Head and Neck Cancer
JOHANNESBURG, South Africa / HYDERABAD, India, Aug. 3, 2026 Dr. Reddy’s Laboratories South Africa announced the registration of an...
Dr. Reddy’s Laboratories Secures U.S. FDA Approval for Rituximab Biosimilar
HYDERABAD, India, Aug. 1, 2026 Dr. Reddy’s Laboratories Ltd. announced that the U.S. Food and Drug Administration (FDA) has...
Evexta Bio and Roche Partner to Evaluate Rupitasertib Combination in Advanced Breast Cancer
PARIS, Aug. 4, 2026 Evexta Bio announced a clinical trial collaboration and supply agreement with Roche to evaluate its...
Sanofi’s MenQuadfi Receives EU Approval for Infants From Six Weeks of Age
PARIS, Aug. 4, 2026 Sanofi announced that the European Commission (EC) has approved an expanded indication for MenQuadfi® (Meningococcal...
Advertisements
Nurix Therapeutics Enrolls First Patient in Phase 3 DAYBreak CLL-306 Trial of Bexobrutideg
BRISBANE, Calif., Aug. 4, 2026 Nurix Therapeutics, Inc. announced the enrollment of the first patient in the registrational Phase...
Candel Therapeutics Announces Extended Phase 3 Data Presentation at ASTRO 2026
NEEDHAM, Mass., Aug. 3, 2026 Candel Therapeutics, Inc. announced that new data from its Phase 3 clinical program evaluating...
Design Therapeutics Reports RESTORE-FA Progress and Advances GeneTAC® Pipeline
CARLSBAD, Calif., Aug. 3, 2026 Design Therapeutics, Inc. reported second-quarter 2026 financial results while providing key clinical updates across...
Altimmune Initiates PERFORMA Phase 3 Trial of Pemvidutide for MASH
GAITHERSBURG, Md., Aug. 3, 2026 Altimmune, Inc. has initiated patient enrollment in the global PERFORMA Phase 3 registrational trial...
Pfizer and BioNTech Win EU Approval for XFG COVID-19 Vaccine
NEW YORK and MAINZ, Germany, July 29, 2026 Pfizer Inc. and BioNTech SE announced that the European Commission (EC)...
Advertisement
